Loading...
Loading...
Contributors:
Dataset URI:
10.6084/m9.figshare.33973192.v2Reliable tracking of short- and long-term blood pressure (BP) changes is a prerequisite for clinical adoption of cuffless BP devices. This study evaluated the 6-week stability of BP estimation by CSEM’s wearable photoplethysmography (PPG)-based cuffless BP monitor and its ability to track BP changes in hypertensive patients compared with a validated oscillometric device (Microlife WatchBP Home A). In this feasibility method-comparison study, 30 hypertensive patients attended four visits over 6 weeks. At each visit, BP was estimated as the median of 5-7 consecutive measurements obtained with the cuff-based (Cuff BP) and cuffless (PPG BP) devices. Between-visit systolic and diastolic BP changes (ΔSBP, ΔDBP) were compared between devices. Concordance rate (CR), defined as the percentage of significant BP changes (ΔSBP >15 mmHg, ΔDBP >10 mmHg) showing the same direction with both devices, was also assessed. Thirty participants (18 women; age 54 ± 17 years; BMI 29.2 ± 5.5 kg/m²) were included. Differences between devices were 0.2 ± 12.8 mmHg for ΔSBP and -0.1 ± 7.4 mmHg for ΔDBP. No temporal drift in differences between Cuff ΔBP and PPG ΔBP was observed over 6 weeks. CR for significant BP changes was 83% for SBP and 86% for DBP. CSEM’s wearable cuffless BP monitor provided stable BP estimation and concordant BP tracking during antihypertensive therapy. Interpretation is tempered by substantial variability of the oscillometric reference device. If confirmed in larger studies against a gold-standard reference, these findings could support the clinical acceptance of wearable cuffless BP monitoring. Blood pressure estimation with CSEM’s wearable cuffless device appears to provide stable performance over a 6-week period without needing recalibration.Concordance rates for tracking significant blood pressure changes exceeded 80% between CSEM’s wearable cuffless device and a validated oscillometric cuff device.The high measurement variability observed in oscillometric cuff devices highlights the need for future comparison with the double-blind auscultation gold standard and raises concern regarding the clinical value and interpretability of isolated oscillometric measurements. Blood pressure estimation with CSEM’s wearable cuffless device appears to provide stable performance over a 6-week period without needing recalibration. Concordance rates for tracking significant blood pressure changes exceeded 80% between CSEM’s wearable cuffless device and a validated oscillometric cuff device. The high measurement variability observed in oscillometric cuff devices highlights the need for future comparison with the double-blind auscultation gold standard and raises concern regarding the clinical value and interpretability of isolated oscillometric measurements.
Keyword(s):
Biological Sciences not elsewhere classified; Biophysics; Biotechnology; calibration stability; change tracking.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)